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The role played by Traditional Medicinal Knowledge (TMK) such as, Ayurveda in personalized and preventive 
healthcare has its foundations in the Humoral Doctrine of Tri-dosha: Vata, Pitha and Kapha. This encompasses the 
manifestation of Panchamahabhutas within the human body thereby exhibiting unique bodily characteristics. Advanced 
pharmacogenomics has scientifically been correlated to the traditionally known genetic attributes of Tri-dosha and human 
body – Prakriti. Simultaneously the advancement of ethnopharmacology has enabled the extraction of plant-derived 
chemical compounds and bioactive constituents in drug discovery leading to commercial manufacturing of modern medicine 
that are a part of global market economy and founded on the western ideals of IPR and monopolistic trade tendencies. This 
has led to the bypassing of Access and Benefit Sharing (ABS) of the Convention on Biological Diversity (CBD) resulting in 
rampant misappropriation and bioprospecting of TMK through obtaining of IP rights without prior approval. This has 
challenged the very subsistence and survival of indigenous and local communities thereby raising a strong necessity for a 
cooperative model of TMK sharing over the prevailing knowledge commercialization, private rights and monopolistic-
capitalistic approaches. The objectives of the research paper is to discuss and understand the scientific validation of 
Tri-doshas, to critically analyze the protection of TMK through IPR, local customary laws & traditions and current national 
and international policy perspectives. Further, the research explores historical roots of modern western medicine to TMK 
and also analyses several cases where objections have successfully been raised by TKDL at the global patent offices against 
the grant of patent to prior art dealing with TMK of India. A detailed case study of the success story of the ‗Kani Model‘ of 
Access and Benefit Sharing has been made to emphasis on cooperative knowledge sharing. 
Keywords:Intellectual Property Rights, Traditional Medicinal Knowledge, Ayurveda, Tri-doshas, Ethnopharmacology, 
Access and Benefit Sharing, Semi-commons, Cooperative Knowledge Sharing, Inter-Governmental Committee 
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The treatment of diseases originally started as a 
sacred and spiritual belief and therefore involved a 
mix of prayers, practices and herbal mixtures thereby 
forming the basis of traditional medicine knowledge 
system among the indigenous and local communities 
in India and at the global level. India has seen the 
evolution, documentation and practicing of traditional 
medicinal knowledge such as Ayurveda and yoga as a 
viable tool of wellness management. Ayurveda is one 
of the traditional medicinal knowledge system that is 
widely practiced in India. The evolution of modern 
medicine too has had its roots in the traditional 
medicine system until the Renaissance and Industrial 
Revolution enabled the gradual advancement of 
technology, understanding of pathology and 
pharmaceuticalisation procedures in a competitive 
globalized market as we see today.
1 
Notably, there 
have also been colonial implications in the inter-
continental exchange of medicinal plant species and 
traditional medicinal knowledge at the global level.
2 
Therefore, the progress achieved in modern medicine 
have evolved out of the empirical knowledge from 
traditional medicinal system such as Ayurveda and 
Siddha from India.
3
Ancient civilizations such as China, Egypt, Greece, 
Mesopotamia, etc. too have roots in traditional 
medicinal knowledge. Having said that a large chunk 
of the global population still use medicines that are 
based on traditional medicinal knowledge systems.
3
 
The 1980s saw the role played by biotechnology in 
the discovery of plant derived pharmaceutical drugs 
thereby causing greater interest among the scientists 
and physicians towards ethnopharmacology and 
traditional medicinal knowledge that were historically 
and customarily protected and carry forwarded by the 
indigenous and local communities. The protection of 
traditional knowledge by deeming it as intellectual 
property first took shape at the 1992 Rio Summit 
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wherein the Convention on Biological Diversity was 
adopted to ensure access and benefit sharing under the 
perspective of ‗semi-commons‘ and prevent bio- 
prospecting of traditional knowledge by third parties.
4
 
The prospects of Semi-Commons enable the greater 
benefit of traditional knowledge to its holders and the 
public through cooperative sharing of knowledge and 
resources.  
 
Evolution of Traditional Knowledge and 
Intellectual Property 
The historical foundations behind the intellectual 
property can be traced back to the industrialization era 
with constant upgradations inorder to suit such 
nations that were leaders in technology and advanced 
scientific research post the Industrial Revolution (IR). 
The First and the Second World Wars proved to the 
world nations that vital scientific knowledge and 
cutting edge technological expertise were crucial for 
the nations to sustain as global and regional 
superpowers. The disintegration of the USSR was just 
the beginning of USA‘s emergence as a monopolistic 
power with the backing of the European Union. The 
‗global north‘ thereafter ensured that the global south 
unitedly marched behind it practically in all aspects, 
particularly in trade relationship. This enabled them to 
have an extra edge over the other nations or societies 
in ensuring that the legal ledgers played an 
advantageous role for the ‗global north‘ over the 
‗global south‘ in terms of knowledge acquisition 
under the garb of Liberalization, Privatization and 
Globalization (LPG).
5
 While there existed an 
established ‗selfless culture‘ of traditional knowledge 
on the principles of cooperation and togetherness in 
the countries of the global south, the global north 
bound the entire world with competition and 
commercialization through the Trade Related Aspects 
of Intellectual Property Rights (TRIPS) under the 
World Trade Organization (WTO) to bring about a 
commonality among the world nations and assert that 
intellectual property is a trade related asset inspite of 
the diversity prevailing in the intellectual property 
regimes of the ‗global south‘ that had originally suited 
their culture, tradition, and indigenous communities. 
The concern that the indigenous people and their 
communities are mainly in the developing and 
underdeveloped countries of the global south have 
demanded equal protection for traditional knowledge. 
As a result in the year 2000, the Inter-governmental 
Committee on Intellectual Property and Genetic 
Resources, Traditional Knowledge and Folklore 
(IGC) was established by the World Intellectual 
Property Organisation (WIPO) so as to develop a 
global legal instrument that would render effective 
protection for traditional knowledge, genetic 
resources and traditional cultural expression / 
folklore. The liveliness and richness associated with 
traditional knowledge is that it has phenomenally 
been developed, sustained and passed on from one 
generation to another in a community. The authorship 
or inventor of any traditional knowledge is mostly 
unknown and the dynamic nature of traditional 
knowledge makes its protection difficult using the 




Intellectual Property and Traditional Medicinal 
Knowledge in India 
A large number of population depend on traditional 
medicine while several of the modern vaccines and 
drugs are based on natural resources and associated 
traditional medicinal knowledge. In India the 
importance of traditional medicinal knowledge with 
regards to the indigenous communities also comes 
with social, cultural and scientific values. As a result 
it has invited recognition, respect, preservation and 
protection from undue commercialisation and 
scientific interest towards traditional medicinal 
knowledge. TMK are mostly derived from plant and 
animal varieties and hence fall under genetic 
resources which are not human creations but occur 
naturally in the nature and therefore cannot be directly 
protected as intellectual property. Intellectual 
Property refers to creation of the mind, such as 
inventions; literary and artistic works; designs; and 
symbols, names and images used in commerce. 
Intellectual Property is protected in law by patents, 
copyright and trademarks which enable people to earn 
recognition or financial benefit from what they invent 
or create. This means that the individual creator or 
inventor holds the rights over his/her intellectual 
property – Intellectual Property Rights/IPR.
7
 
The World Health Organization (WHO) defines 
traditional medicine as ―the sum total of the 
knowledge, skills and practices based on the theories, 
beliefs and experiences indigenous to different 
cultures, whether explicable or not, used in the 
maintenance of health, as well as in the prevention, 
diagnosis, improvement or treatment of physical and 
mental illnesses‖ wherein ‗traditional‘ means the 
knowledge that is created in a manner that reflects 
community traditions that have been created, 




preserved and transmitted from generations and held 
collectively. Though the indigenous community may 
innovate, the fact which deems their innovation is 
based on the community‘s collective heritage that it 
has held. WIPO, through its Intergovernmental 
Committee on Intellectual Property and Genetic 
Resources, Traditional Knowledge and Folklore, 
seeks to develop international legal instrument that 
would provide effective protection of Traditional 
Cultural Expressions, Folklore and TK – including 
traditional medicinal knowledge.
8 
Though, there are a 
multitudinal definitions that cover various areas of 
traditional knowledge, a holistic definition for 
traditional medicinal knowledge with all its features 
and aspects concerning indigenous rationale, 
sustainability and customary self-regulations is 
required so as to understand the indigenous and local 
communities in its truest essense.
9 
Therefore, a 
contextual definition for Traditional Medicinal 
Knowledge is: 
―Traditional Medicinal Knowledge is associated 
with indigenous communities that are unique and 
derived through observations from the nature, 
surrounding environment and then transmitted, 
originally orally, from one generation to another 
throughout the world.” 
Traditional Medicinal Knowledge with its spirit  
of local - collective ownership characterizes the 
continuousness of spiritual belief, diverse culture, 
dynamic wisdom, collective heritage, sacred values, 
time tested sustainable practices that are ancestrally 
inherited within the indigenous & local communities 
and their social world. This time proven nature of 
Traditional Medicinal Knowledge system is such  
that it precisely provides the indigenous and local 
communities with the required knowledge, wisdom, 
practices and purpose of their existence by 
simultaneously enabling the communities to live in 
harmony with the ecosystem and uncompromisingly 
adapt themselves to ecological changes. Such holistic 
interconnectedness between community level activities 
of humans and various components of mother nature 
over a prolonged period of time with a scope to adapt 
to change is what distinguishes Traditional Medicinal 
Knowledge from that of modern western medicine. 
 
Role of Panchamahabhuta and Tri-dosha in 
Ayurveda 
Traditional Medicinal Knowledge Systems 
(TMKS) such as, Ayurveda, uses combinations of 
physiological exercises, massages, meditation, diet 
modification, medicines derived from indigenous 
plants, animal products and minerals for the treatment 
of ailments.
10
 The fundamental aspect of the healing 
and treatment in TMKS is based on the theoretical 
understandings of the Panchamahabhutas and the Tri-
doshas. According to Charaka, the famous physician 
from ancient India, it is the doctrine of tri-doshas that 
dominates the theory and practice of traditional 
medicinal knowledge systems such as Ayurveda and 
are not just theoretical concepts but real substances.
11
 
The five eternal and base components of nature or the 
Panchamahabhutas are Prithvi (Earth), Apa (Water), 
Agni (Fire), Vayu (Wind) and Aakasha (Ether). All 
the living and non-living beings including the human 
body are created from the permutations and 
combinations of different variables or the components 
of Panchamahabhutasthereby making every 
individual as a unique entity in relation to the external 
environment from the preview of Ayurveda.
12 
This is 
to precisely say that human body is a ‗miniature form 
of nature‘ wherein the similar components of the 
nature are present in our body. The following 
description of the properties of Panchamahabhutas 
with regards to our body is important: 
(i) Prithvi or earth is the basic gross element which 
gives the sense of smell and is characterized with 
mass, density, opacity and inertia.  
(ii) Apa or water is the element of aqua or liquids and 
possesses the characters of fluidity, coldness, 
viscosity etc 
(iii) Agni or fire is the thermal element and is related to 
digestion. Agni also represents the manifestation of 
anger, passion and courage in the human body. 
(iv) Vayu or air is the basic gaseous element and 
possesses the characteristics of lightness. 
(v) Akasha or Ether is related to space and enables 
sound and hearing. They form the pores, cavities 
and channels in the human body. 
Panchamahabhutas control various activities of 
our body through the Tri-doshas or body humours 
which are the three vital energies of our body namely 
Vata (wind), Pitta (bile) and Kapha (phlegm). 
Further, each of the doshas are composed of two of 
the Panchamahabhutas and perform anatomical 
activities as: 
1. Vatahas the primary elements of Vayu (air) and 
Akasha (ether) with the functional control over 
movement and communication.  




2. Pitta has the elements of Agni (fire) and Apa 
(water) to functionally oversee digestion, 
metabolism and transformation.  
3. Kapha has the elements of Apa (water)  
and Prithvi (earth) to functionally provide 
cohesiveness, body structure and lubrication.  
Each person contain the unique blend of these 
doshas. So the core and foundational aspect of health 
and disease as per the principles of Ayurveda is 
centred in the uniqueness of an individual. However 
most of them have one of it as a dominating doshas 
which form the true nature of the body or the 
prakriti.
13
 The Tri-doshas are present in varying 
proportions in the human body and tend to form 
specific body signatures according to the dominant 
dosha of our body to form distinct prakriti or the 
nature of the body. Just like the Panchabhutas create 
atmospheric, climatic and physical changes in the 
surrounding nature, they also affect our bodily 
wellbeing through different proportions and 
combinations in the form of doshas. M. S. Valiathan 
in his book, ―The Legacy of Charaka‖ writes ―While 
the homology between the structural materials  
within the body and outside, in the physical world,  
is the theme of the pancabhuta doctrine, the 




Therefore, the role played by the Tri-doshas in our 
body and mind are crucial for its survival, 
metabolism, endurance, health, and disease 
prevention apart from determining of physical and 
mental characteristics of our body. The ratio of vata, 
pitta and kapha influence the human body in its 
individual features, mental and emotional character 
and traits as well as our unique strengths and 
vulnerabilities. Every dosha has a quality and bodily 
manifestations of its own. Any deficiency or 
excessive quantity of the tri-doshas is said to unsettle 
a condition of health disorders and disturbances. 
Ayurveda also prescribes several lifestyle oriented 
remedies and adaptations to ensure the equilibrium of 
the doshas.
13
 Ayurveda not only stresses on the 
physical nature of the body but also on the 
psychological aspect of the individual and a holistic 
approach towards diet and lifestyle inorder to 
maintain health and prevent disease.
14
 
It is also important to understand the specific  
dosha properties and the detailed results of their 
balance and imbalances in the human body as shown 
in Table 1.
15 
The following shloka from the Susruta Samhita 
describes as to what ‗health‘ is according to 
Ayurveda, a traditional medicinal knowledge  
system: 
Samadosha Samagnischa Samadhatumalakriyaha 
Prasannatamenindriyamanaha Swasthya 
Ityabhidheeyate 
It means ―When the doshas are in balance 
(samadosha); when the different forms of agni are in 
balance (samagni); when the processes are associated 
with the creation of dhatus and mala are in balance 
and working seamlessly; when the atma (soul); the 
sense organs (jnanendriya and karmendriya) and the 
mind (manaha) are in a state of happiness and 




The vaidyas or the traditional healer understands  
the particular prakriti that the human body is 
predominantly associated with for diagnosis of 
ailments. The treatment is given in accordance with the 
imbalance of dosha in a person. TMKS provide the 
scope and relevance towards personalized medicine 
and prevention system through the better understanding 
of the body type or prakriti thereby making Ayurveda a 
universal concept of traditional medicinal system that 
can be associated with the concepts of science. 
Personalised preventive medicine is of greater 
advantage in the case of Ayurveda wherein other non-
traditional systems of medicine have the scope of only 
personalized medicine.
17 
The prakriti signature is 
unique from one person to the other and this has been 
validated and evidenced by modern science. 
 
Scientific Validation of Tri-doshas 
The article titled, ―DNA methylation analysis of 
phenotype specific stratified Indian population” 
published in the Journal of Translational Medicine 
has elaborately reported that the respective doshas of 
vata, pitta and kapha were experimentally correlated 
with their known characteristics of motion (vata), 
higher metabolism (pitta) and structural attributes 
(kapha). The experimental research method involved 
had been the sampling of whole blood DNA samples 
of individuals whose ayurvedic prakriti specimens of 
vata, pitta and kapha was earlier known. The  
samples were ‗subjected to methylated DNA 
immuno-precipitation (MeDIP) and microarray 
analysis. After data analysis, prakriti specific 
signatures were validated through bisulfite DNA 
sequencing‘. The research also concluded that the 




differential DNA methylation signatures of all  
three doshas showed the genetic basis of traditional 
human classification system, in accordance with 




Another study determined the genetic basis of 
doshas, in varying proportions of dominance, which 
were as described in the Charaka Samhita by 
performing SNP (single nucleotide polymorphism) 
analysis of the three prakritis. The results were also 
independently confirmed by ‗AyuSoft‘ which is a 
software developed on the basis of classical ayurvedic 
literature.
19
 The scientific and genetic basis for body‘s 
prakriti have been distinguished and differentiated 
with individuals of pitta-prakriti having faster 
metabolism and those of kapha-prakriti having  
slower metabolism thereby enabling drug discovery, 
pharmacogenomics and personalized medicine.
20
 A 
better understanding of dosha theory as abided in 
Traditional Medicinal Knowledge system such as 
Ayurveda from the perspective of genetic and 
biotechnological research have opened the scope for 
pharmacogenomics which is but the study of genetic 
response with regards to variations and responses to a 
drug thereby utilizing the genetic information in 
preventing an adverse reaction.
14 
Simultaneously, 
genomic research have shown correlations between 
genetic patterns and doshas thereby impacting 
physiological and psychological applications.
21 
The 
Prakriti of human body has genetic connotation  
that are totally based on the dosha cluster thereby 
making every individual as a unique entity in terms  




Table 1 — Specific dosha properties and its result in the human body 
State of human 
body 
Vata Pitta Kapha 
Constitution  Involved in breathing and eye 
movement 
 Motor functioning 
 Cell functioning 
 Easily excited, alert without 
thinking much before constant 
action 
 Thin, light and flexible body 
 Involved in body metabolism 
 Involved in appetite, food digestion and 
absorption, transformation and 
transportation for assimilation of 
nutrition into the body and dispelling of 
waste products 
 Cell functioning 
 Neurotransmission and neuropeptides 
in intelligence 
 Vitality 
 Learning and understanding theories 
and concepts 
 Seldom gains or loses weight nor has 
weight fluctuations 
 Disciplined leaders 
 
 Involved in body structure and the 
stability of the structure 
 Involved in water metabolism and 
fluid distribution throughout the 
body 
 Lubricates cells, tissues, joints and 
organs 
 Cell functioning 
 Chubby shape 
 Retention of knowledge for 
memory 
Balanced  Personal creativity & 
accomplishment 
 Courage 
 Intelligence and understanding  Expression of love and 
compassion 
 Faith and devotion 
 Melodious voice and speech 
patterns 
 Longevity in life 
 Feelings of calmness 
 Forgiveness and benevolence 
 
Unbalanced  Fear, worry, and anxiety 
 Problems with motor 
functioning, nimbleness, and 
dexterity 
 Fear of loneliness 
 Boredom 
 Anger, hatred, and jealousy 
 Perfectionism 
 Judgemental and critical 
 Problems with inflammation leading to 
chronic disorders and heart diseases 
 Addictions and unhealthy 
attachments to things, substances 
and people 
 Calculating greed and ruthlessness 
 Disorders involving the congestion 
of fluids trapped in various places 
within the body. 
 Slow digestion and weight gain 
 Cravings for sweet and salty food 
 Idleness and long periods of 
sleeping 




TMK and IPR: Cases of Modern Medicines 
Derived from Traditional Medicine 
The therapeutic use of traditional medicinal plants for 
the treatment of human diseases has been in practice in 
many of the cultures and societies across the globe. This 
has also, over the period of time, led to the development 
of various independent and organised medicinal systems 
in accordance with the geographic availability of various 
species of medicinal plants until they were finally 
institutionalized from the modern perspective. A large 
population of the developing countries depend on 
Traditional Medicinal Knowledge as it is an available 
and affordable source of treatment for various ailments. 
With the aid of modern sciences and technological 
tools it has become possible to extract active drug 
compounds from the medicinal plants and this has 
become possible because the medicinal plants are 
naturally capable of amalgamating thousands of such 
individual bioactive constituents from the soil and 
environment that are rooted to it. Plant derived 
chemical compounds have thereby enabled the 
manufacturing of modern medicine and it has been 
scientifically correlated that the diagnosis based on 
traditional medicinal plant and that of chemical 
compounds derived from the active compounds of the 
plant happen through similar process and mechanism. 
Therefore, traditional plant based medicines are as 
effective as the modern - conventional medicines while 
Traditional Medicinal Knowledge continue to be the 
foundational base for the development of modern drugs 
as they are the best source for obtaining a variety of 
drugs.
25
 Since the plant – derived drugs continue to be 
an inevitable source of new drug discoveries and 
opportunities they are also the simultaneous interjecting 
points of global platform for pharmaceutical market 
economy, determining factor for the stability of 
pharmaceutical markets worldwide, intellectual property 
rights and bio-prospecting of Traditional Medicinal 
Knowledge, habitat degradation and sustainable 
exploitation of natural resources, tropical forest-




The Materia Medica of Ayurveda contain 8000 
known medicinal recipes made of herbs, metals, 
minerals, animal products and their ash in right 
proportions and a systemic therapy.
25
 Further, the 
detailed study of ethnopharmacology and traditional 
medicine have led to several natural products, drug 
discoveries and several pharmaceutical companies 
have altered their strategies accordingly to differing 
guidelines of standardization, manufacture and quality 
control. Importantly, the process of reverse 
engineering towards traditional knowledge driven 
drug development by adopting reverse pharmacology 
path with much faster and cheaper cost with the help 
of modern technologies have found scope too. 
27
 
In this regard, Traditional Medicinal Knowledge 
involves themedicinal use of plants and herbs that 
form the integral part of genetic resources and are 
therefore not the original creation of the human 
intellect and hence does not qualify for protection as 
an intellectual property. Moreover, the Traditional 
Medicinal Knowledge have been guarded, preserved 
and held as collective heritage by the indigenous and 
local communities as a part of their cultural traditions 
that have been continuing for several generations. 
Such time-proven knowledge have also been a source 
of subsistence and survival for the indigenous and 
local communities and therefore any intention to 
commercialiseTraditional Medicinal Knowledge 
should happen in accordance with the Access and 
Benefit Sharing (ABS) mechanism of the Convention 
on Biological Diversity (CBD). Instances of patents 
granted to plant based genetic resources involving 
Traditional Medicinal Knowledge such as, turmeric 
and neem had invited criticism thereby resulting in 
subsequent revoking of the patents that were awarded 
to them. Prevention of misuse and misappropriation 
of Traditional Medicinal Knowledge is therefore 
crucial. Inspite of this the global attraction garnered 
by Traditional Medicinal Knowledge has been 
immense due to the growing side-effects of allopathic 
medicines and therefore, the systems of traditional 
medicinal knowledge has become subject to biopiracy 
and patenting. The development of the Traditional 
Knowledge Digital Library (TKDL) by Council of 
Scientific and Industrial Research (CSIR) to prevent 
the misappropriation of traditional medicinal 
knowledge from awarding of patent at the 
International Patent Offices by scientifically 
classifying India‘s Traditional Medicinal Knowledge 
systems such as Ayurveda, Siddha, Unani and Yoga 
into a multi-language searchable database is therefore 
important in this regard. 
28
 
While this is the case, patents for products, 
formulation, compositions and processes for 
traditional ayurvedic medicine, medicinal plants and 
herbal based formulations have well been granted to 
several of Indian and foreign entities. Table 2 shows 
some of the patents that have been granted in India.
29 














Patent grant title Main herbs described in the patent 
1. 155/MUM/2008 20/04/2011 247558 Herbal extract and  
ayurvedic composition for 
the treatment of diabetes 
Momordica charantia 
2. 1734/KOL/2007 17/08/2011 248741 A process for preparing an 
ayurvedic medicament 
effective against leukaemia 
and carcinoma of lung and 
intestine 
Lime, Asafoetida and Black jeera 
3. 1938/DEL/2006 29/03/2010 239637 A process for preparation  
of ayurvedic composition 
 for treatment of hepatic 
disorder 
Kaghzinimbu (Lemon) Citrus medica 
(aurantifolia); Sarjika Salsola kali Linn., Fagoni 
acretica Linn., Barilla and Varat (Kapard) Cyprae 
amoneta 
4. 1623/MUM/2006 03/072008 221770 An ayurvedic composition 
for oral consumption in 
treatment of heart diseases 
and hypertension 
Arjuna - Terminalia arjuna, Ajamoda– Apium 
graveolens,Punarnava–Boerhavia diffusa, Rasona 
- Allium sativum, Shigru–Moringa oleifera, 
Draksha–Vitis vinifera, Pippali - Piper longum, 
Guduchi–Tinospora cordifolia, and  
Triphala 
5. 228/CHE/2006 30/07/2010 241922 A process for the  
preparation of  ayurvedic 
tooth powder/paste 
Azadirachta indica, menthol, thymol, camphor  
and gall nut 
6. 3207/DEL/2005 28/09/2007 210329 An ayurvedic composition 
for joining fractured bone & 
as anti-inflammatory and 
process for preparation 
thereof 
Cissus quadrangularis, Pterocarpus marsupium 
heartwood, Buffalo/Cow Milk and Chenopodium 
murale (kurund) 
7. 313/CHE/2005 05/02/2009 228654 A unique combination of 
ayurvedic compounds for 
correcting a rare form of 
Mullerian dysgenesis 
Asoka, Asana and Bilwa, Shorea robusta Gaertn, 
Pinus roxburghii Sargent, Cyperus rotundus 
Linn., Sidar hombifolia, Gmelina asiatica Linn., 
Nardostachys jatamansi DC, Randia dumetorum 
Linn., Kaemferia galangal Linn., Teramnus 
labialis Spreng., Phaseolus trilobus Ait., Inula 
racemosa Hook F, Cinnamomum zeylanicum, 
Syzygium aromaticum Merr., Parmelia 
(Sangejaranath), Crocus sativus Linn., 
Cinnamomum camphora T. Nees and Ebem 
8. 146/MUM/2005 09/01/2009 227476 An ayurvedic herbal hair oil 
composition and preparation 
thereof 
Jatamasi (Nardostachys jatamansi (D. Don) DC.), 
Amla Bramhi (Gratiola), Bhrungaraj (Eclipta 
alba) thistles, Nagamothra (Cyperus rotundus), 
Kapurkachari (Hedychium spicatum) and Kavath 
(Feronia elephantum) 
9. 2352/DEL/2004 01/11/2007 211481 An ayurvedic composition 
useful for the treatment of 
migraine 
Psidium guava and Eucalyptus Camel dulensis 
10. 1145/MUM/2004 13/11/2009 236637 A process for preparation of 
ayurvedic anti-snake venom 
capable of administering 
orally or intravenous 
Jasminum sambac, Erythina indica, Eugenia 
jambolana and Mangifera indica 
     (Contd.) 
 















Patent grant title Main herbs described in the patent 
11. 611/MUM/2004 10/01/2008 213692 A process to prepare a novel 
ayurvedic composition and 
the composition resulting 
there from 
Terminalia arjuna bark, Hemidesmus indicus root, 
Mangifera indica bark, Moringa oelifera bark, 
Murraya koenigii leaf, Piper longum fruit, 
Boerhavia diffusa root, Achyranthes aspera root, 
Rauwolfia serpentine root, coconut oil, sunflower 
oil, cashewnut oil, groundnut oil, linseed oil 
(refined) and sesame oil 
12. 1048/MUM/2003 17/04/2007 206091 Ayurvedic immuno 
modulator composition  
for treatment of acquired 
immuno deficiency 
syndrome 
Guduchi or  Giloe (Tinospora cordifolia),  Panash or 
Kathal (Jack fruit), Tulsi or Krishna Tulsi (Holy Basil), 
Kuda or Kutaja (Kurchi) Bhui Amla or Bahu Patra 
(Gooseberry), Gingko biloba Shilajeet or Silaras 
(Asphaltam), Karavella or Karela (Bitter gourd) 
13. 553/KOL/2003 20/11/2007 212143 A process for preparing 
nutrient fortified ayurvedic 
sweets like Sandesh and 
Rosogolla containing at  
least one herb 
Tulsi (Osimum sanctum) leaves Pudina 
(Menthaaervensis) leaves, Coriander (Coriandrum 
sativum) leaves Tender mango (Mangifera indica) 
leaves, Stone apple (Bael - Aegle marmelos) leaves, 
Spinach (Spinacia oleracea), Carrot (Daucus carota) 
Beet root, Cucumber, Kulekhara (Asteracantha 
longifolia), Shushni (Marselia quadrifolia) Karipata, 
Ashawagandha (Withania somnifera), Guduchi 
(Tinospora cordifolia), Amla (Embica officinalis), 
Shilajeet (Black bitumen or mineral pitch), 
Suvambhasm (incinerated gold), Mandookparni 
(Bacopa monnieri), Mulethi (Glycirrhiza glabra), 
Shankkapushpi (Convolvulus alsinoides),  
Vijaysara (Pterocaspus marsupium), Katuka 
(Picrosshiza kurroa), Vidang (Abies webiana),  
Bakuchi (Psoralia corylifolia), Bhallatak 
(Semecarpurs anacardium) Brahmi (Centella 
asiatica), Arjun bark (Terminalia arjuna), Ashok 
bark (Saraca indica), Bael leaf (Aegle marmelos), 
Clove fruit (Myrtus caryophyllus), Dalchinibark 
(Cinnamomum zeylanicum), Elaichi fruit (Elettaria 
cardamomum), Ginger rhizome (Zingber officinale), 
Grapeseeds (Citrus paradisi), Gorgon nuts, Walnuts, 
Almonds, Cashew nuts, Ground nuts, Hing (Ferula 
asafoetida), Orange peel, Jatamanshi (Nardostchyas 
jatamansi) – Extracts from skin of Lemon & Grape 
fruit, Jayphal fruit (Myristica fragrans), Liquorice 
(Glycyrrhiza glabra), Cucumber seeds, Tea leaves 
Spirulina, Dates, lemon grass, mango, papaya, lichi, 
pineapple, guava, banana, apple, fig, coconut milk 
cream, roseberry, etc. 
14. 1048/MUM/2003 17/04/2007 206091 Ayurvedic immuno 
modulator composition  
for treatment of acquired 
immuno deficiency 
syndrome 
Guduchi or Giloe (Tinospora cordifolia), Panash 
or Kathal (Jack fruit), Tulsi or Krishna Tulsi 
(Holy Basil), Kuda or Kutaja (Kurchi) BhuiAmla 
or Bahu Patra (Gooseberry), Gingko biloba 
Shilajeet or Silaras (Asphaltam), Karavella or 
Karela (Bitter gourd) 
15. 1049/MUM/2003 14/02/2007 203986 Ayurvedic anti retro viral 
composition 
for treatment of acquired 
immune-deficiency 
syndrome 
Guduchi (Tinospora cordifolia),  
Panash (Artrocarpus integrifolia), Tulsi (Ocimum 
sanctum), Kuda (Holarrhena antidy scentrica) and 
Bhumi Amla (Phylanthus niruri) 
     (Contd.) 




Apart from these patents for drugs and cosmetics, 
chemical compound extracts and compositions that 
are derived from Indian plants and herbs have also 
been granted to several allopathic pharmaceuticals. 
The TKDL enlists several such patent applications at  
various international patent offices on the likes of 
United States Patent and Trademark Office (USPTO), 
European Patent Offices (EPO), Canadian Intellectual 
Property Office (CIPO), German Patent and 
Trademark Office (DPMA), United Kingdom Patent 
& Trademark Office (UKPTO), IP Australia and 
Controller General of Patents Designs and 
Trademarks (CGPDTM India) on objections raised  
by the TKDL with respect to the grant of patent  
for ‗Prior art‘ concerning India‘s Traditional 
Medicinal Knowledge and systems. There exist a  
total of 239 cases wherein objections have been 
submitted by the TKDL in the above international 
patent offices at the pre-grant stage of patent thereby 
resulting either in the withdrawal, cancelling, 
nullifying, termination or leading to necessary 
amendments over the claim to patent by the  









Patent grant title Main herbs described in the patent 
16. 717/DEL/2003 19/11/2010 244133 A process of preparing said 
synergistic herbal ayurvedic 
ointment for the treatment  
of analgesic, rheumatoid 
arthritis, backache, 
spondilitis, sprains, joint 
pains, headache, cold, 
inflammations and  
muscular pain 
Cinnamom camphora, Mentha arvensis, 
Commiphora mukul (Gulggulu) and Syzygiu 
17. 459/MUM/2003 24/05/2007 207188 Process for preparation of 
skin care composition by 
combining micro nutrients 
with ayurvedic substances 
Haridra, Raktachandana, Manjistha, Kumari, 
Almond Oil and Coconut Oil 
18. 22/MUM/2003 20/07/2007 208269 A process of preparing an 
ayurvedic composition for 
treatment of cold, pain, 
cough, etc. 
Poppy, Cowith,  Hycosxix orsiodiasis, Salvia 
plebia, Nutmeg, Mace, Clove and Cardamom 
19. 56/BOM/1998 24/08/2001 183805 A process for the  
preparation of an  
immuno modulator from the 
ayurvedic medicinal plant, 
gulvel (Tinospora sp.) 
 Gulvel (Tinospora sp) 
20. 667/BOM/1997 27/07/2007 208438 Oral herbal ayurvedic 
composition for treatment  
of psoriasis 
Matricaria chamomilla and Piper nigrum 
(only seeds) 
21. 668/BOM/1997 27/07/2007 208437 Herbal ayurvedic 
composition for 
treatment of psoriasis 
Psoralia corylifolia (only seeds),  
Santalum album Linn., Cassia occidentalis 
(roots), Matricaria chamomilla (whole plant) 
22. 423/BOM/1997 01/01/2000 183487 An improved process for 
manufacture of the extract 
obtained from ayurvedic 
medicinal plant, Guduchi 
Guduchi (Tinospora cordifolia) 
23. 1471/DEL/1996 17/01/2008 213809 An ayurvedic eye drop 
composition for treatment  
of various eye diseases 
particularly in 
improvingeye-sight by the 
flatting of the cornea and 
interior surface of the lens 
Apamarg (Achyranthu saspera), Punarnava 
(Boerrhavia diffusa), Plash  
(Butea monosperma), Fitkari (Alum), Tuth 
(Copper Sulphate), Peppermint (Mentha piperata), 
Taknamal (Borax), Yashad (Zinc Sulphate) 
Source: IPR issues related to medicinal and aromatic plants (herbs &their allied products), Journal of Traditional Folk Practices 
 




patent examiners. As a result, TKDL‘s submissions 
and reference to prior art has made definite 
contributions in preventing misappropriation and 
preventing attempts towards patenting existing 




Table 3 enlists some of the patents applications at 
various international patent offices over the period of 
time that were rejected, withdrawn or amended due to 
TKDL‘s objection and providing prior art evidences 
regarding Traditional Medicinal Knowledge and 
Indian medicine system. 
 
Roots of Modern Western Medicine in TMK 
The roots of western medicine too is founded on 
the basis of traditional humour based medicine that 
are similar to those of the Tri-doshas and had plant 




century, European Medicine depended 
on the indigenous medicine system wherein the 
components of drugs were availed from natural 
products such as plants and their parts that were 
available from the mediterrane an region and with the 
Middle East, Asia, and the Americas contributing 
knowledge and materials in the medieval and early 
modern periods and therefore a large number of 
Traditional European Pharmaceutical writings that 
can be located to the mediterranean region that were 
compiled by the physicians of Greece, Rome, 
Byzantine and medieval Islamic with the earliest 
dating back to 500 BC uptill the 19
th
 century AD  
that reveal the earliest tradition and imprints of 
Western - European Ethnopharmacology by providing 
plant, animal and mineral based medicinal 
informations and therapeutic formulations that cured 
diseases from time to time.
1
As multi-disciplinary 
studies on pharmacology from the historical 
perspective reveal European herbal medicines were 







Instances of medicinal plant 
species introduced from other continents during 
European colonization show the importance accorded 
to Traditional Medicinal Knowledge.
2
 
Inspite of having such a tradition in the history of 
European medicine which forms the foundation of 
modern western medicine, the effectiveness of TMK 
and herbal medicine is termed as unscientific and 
therefore brushed off as invalid and ineffective.
4
 
Importantly we have already discussed the 
widespread urge and exhaustive efforts by 
pharmaceutical companies to discover new drugs and 
develop modern allopathic medicines from 
Traditional Medicinal Knowledge by obtaining 
Intellectual Property Rights that emphasise on 
knowledge commercialization and bioprospecting.
29
 
The role played by renaissance and industrial 
revolution with regards to advancing science and 
technology played a role in altering the history of 
pharmacy and medical chemistry thereby causing the 
gradual diminishing of traditional medicinal use and 
rise of pharmaceutical companies with economical 
motives. The change of attitude from traditional 
medicine towards medical science in Europe was seen 
in 19
th
 century and to study the ancient sciences was 
considered waste as against scientific experimentation. 
In 20
th
 century the scientific discovery of life saving 





Success Stories of ‘Access and Benefit Sharing’ 
and Protection of TMK 
Amidst past instances of unauthorized use and 
misappropriation of traditional medicinal knowledge 
by third parties, there are also success story models 
that have taken prior consent from the indigenous and 
local communities who are the holders of Traditional 
Medicinal Knowledge by sharing the benefits of 
access and commercialisation by patenting chemical 
compounds that are derived from plant based 
Traditional Medicinal Knowledge. 
 
From Arogyapacha plant to ‘Jeevani’: The 
Traditional Medicinal Knowledge of the Kani 
Tribe 
The indigenous Kani tribe inhibit the wind-ward side 
of Agasthyamalai hills in the tropical forests of 
Western Ghats in the state of Kerala.
33 
The Plathi 
who are the tribal physicians of the Kani tribe 
‗customarily‘ hold the exclusive Traditional 
Medicinal Knowledge belonging to the community 
and they alone have the right to transfer and 
disseminate their Traditional Medicinal Knowledge 
which includes the use of wild plants as medicines. It 
was in December 1987 that an ethnobotanical 
expedition team from the All India Coordinated 
Research Project on Ethnobiology (AICRPE) led by 
Dr. Palpu Pushpangadan who was then the director of 
the Jawaharlal Nehru Tropical Botanical Garden and 
Research Institute (JNTBGRI) in Kerala noticed the 
‗untiring‘ Kani guides while the expedition team  




Table 3 — Patents applications at various international Patent Offices 
S. 
No 
Patent publication  
number and date 
Name of Patent Office and 
application title 
Date of objection by 
TKDL for patent 
grant 
Traditional Medicinal 
Knowledge - prior art 
evidence given by TKDL 
Remarks 
1. EP1747786,  
26 July 2006 
EPO; Natural product in  
cream with anti-vitiligo 
therapeutic properties 
8 July 2009 Cucumismelo or Snake 
Cucumber; Urvaru/ Kakri/ 
Vellarikkai 
Intention to grant Patent 
refused on 27 July 2009 
leading to closing of 
application on  
11 October 2011 
2. 109/DELNP/2007; 
4 January 2007 
CGPDTM, India; 
Composition comprising  
Neel oil and oil extract of 
Hypericum perforatum 
7 February 2013 Azadirachta indica 
A Juss or Neem; 
Nimba/ Neem/ Vembu/ 
Patent application 
refused on  
14 September 2018 
3. 3387/DELNP/2004; 
1 November 2004 
CGPDTM, India; 
Formulations useful in the 
treatment of male and female 
impotence 
7 November 2012 Tribulus terrestris or 
Bullhead Gokshura/  
Nerunjil/ Thirikandam. 
Turnera diffusa or Damiana 
Cinnamomum cassia or 
Cinnamon; Tvak/ Daarchini/ 
Lavangapattai 
Patent application 
refused on  
17 October 2013 
4. EP1660007,  
11 August 2004 
EPO; Compositions for 
diabetic treatment and 
prophylaxis 
 Gymnema sylvestre or  
Miracle Fruit; Madhunashini 
/ Sirukurinjan/ Athingam/ 
GurmarButi  
Decision to refuse patent 
on 27 June 2012 leading 
to closing of application 
on 10 October 2012 
5. 1962/MUM/2008, 
16 September 2008 
CGPDTM, India; 
A herbal formulation for 
treating sickle cell disease 
1 June 2012 Phyllanthus emblicaor 
Indian Gooseberry; 
Amlak/ Aamla/ Nelli 
Myristica fragrans Houtt or; 
Nutmeg; Jatiphala/ Bisbasa/ 
Jathikai/ Kulakkai. 
Zingiber officinal Roscoe or 
Ginger; Ardraka/ Sunthi/ 
Inji/ Chukku 
Leptadenia reticulata – 
Jivanti/ Palaikodi/ Pala. 
Terminalia 
chebulaorMyrobalan; 
Haritaki/ Halelah/ Kadukkaai 
Tinospora cordifolia or 
Tinospora; Guguchi/ Gilo/ 
Seendhil/ Amirdhavalli 
Asparagus racemosus or 
Indian Asparagus; Shatavari/ 
Satawar/ Seemai Sathaveri/ 
Kilavari 
Punica granatum Linn or 
Pomegranate; Dadim. 
Piper longum Linn. or Long 
Pepper; Pippali/ Filifil Moya/ 
Thippili 
Plumbago zeylanica or 
Leadwort; Chitrak/ Sheetraj/ 
Chithiramooam/ Venkodiveli 
Aloe barbadensis Mil l or 
Aloe Vera; Kumari/ 
Gheekawaar/ Sibr/ Katrazhai 
Patent application 
refused on  
12 December 2013 
     (Contd.) 




experienced constant fatigue and tiredness throughout 
the expedition across the rough terrain. The 
expedition team was curious in knowing the reason 
and had observed that the Kani guides intermediately 
ate certain black berry fruits of some plants. These 
fruits were also offered totheexhausted expedition 
team by the Kani guidesandthe team 
instantlyexperienced unusual increased level of 
energy and vitality in them. Due to the traditional 
tribal culture and customary laws that are practiced 
among indigenous communities for the protection and 
preservation of traditional knowledge the Kani guides 
had also initially refused to share the details of the 
plant that bore these edible ‗fruits of energy‘ as this 
Table 3 — Patents applications at various international Patent Offices (Contd.) 
S. 
No 
Patent publication  
number and date 
Name of  Patent Office and 
Application title 
Date of objection by 
TKDL for patent 
grant 
Traditional Medicinal 
Knowledge - prior art 
evidence given by TKDL 
Remarks 
6. 201001732022, 
22 March 2010 
USPTO ; 
Composition for treatment of 
Diabetes mellitus and 
metabolic syndrome 
3 August 2010 (a) Momordica charantia or 
Bitter gourd; Karbellam/ 
Karela/ Pavakkai  
(b) Emblica officinalis or 
Indian gooseberry;  
Aamlak/ Amla/ Nelli/ 
(c)Trigonella foenum-gracum 
or Fenugreek; Methi/ 
Vendhayam/ Uluva 
(d) Curcuma longa or 
Turmeric; Haldi/ Manjal 
Patent claims rejected on 
19 September 2012 
leading to abandonment 
of application 
7. EP2464363,  
11August 2010 
EPO; Natural extract from  
whole banana fruit 
23 May 2014 Musa paradisiacal Linn. or 
Edible Banana/ Plantain; 
Kadali/ Kela/ Vazhai 
Decision to refuse grant 
of patent on 20 March 
2015 leading to closing 
of application on  
7 July2015 
8. EP2435057,  
28 May 2010 
EPO;Compositions and 
methods for modulating lipid 
composition 
20 March 2013 Origanum vulgare Linn or 
Common or Wild marjoram, 
Oregano; Maruvaka/ Ban 
tulsi, Mirzanjosh 
Rosmarinus officinalis or 
Rosemary; Rujamari/ 
Gulmehendi/ Thalisabatri 
Decision to refuse grant 
of patent on 17 June 
2015 leading to closing 
of application on 28 
August 2015 
9. CA 2572031;  
29 June 2005 
CIPO; Fat combustion 
accelerator 
24September 2010 Pinus roxburghii Sargor 
Himalayan long leaved  
pine; Sarala/ Kilima/ 
SeemaiDevadaru 
Patent application 
declared as dead on 
 29 June 2011 
10. 2011257388;  
23 May 2011 
IP Australia; Tamarind seed 
polysaccharide for use in the 
treatment of inflammatory 
diseases 
6 February 2016 Tamarindus indica Linn or 
Tamarind; Imali/ Tamar 
Hindi/ Imli/ Puli/ Amilam/ 
Sinduram 
Patent claims amended 
on 23September 2016 
11. 20120231032,  
3 May 2012 
USPTO; Agent for expelling 
parasites in humans, animals 
or birds 
25 February 2013 Ferula asafoetida regel or 
Asafetida; Hingu/ Heeng/ 
Perungayam/ Ingu 
Rejection of Patent 
claims on 24 June 2013 
on the basis of India‘s 
Traditional Knowledge 
12. 20140106002, 
15 March 2013 
USPTO; Homeopathic 
composition and method for 
the treatment of skin irritations 
and other skin diseases 
17 October  2013 Aloe barbadensis Mill or 
Aloe Vera; Kumari/ 
Gheekawaar/ Sibr/  
Katrazhai 
Patent claims rejected on 
6 January 2015 
13. 20150174185,  
15 January 2015 
USPTO; Viral trappers 12 November  2015 Tephrosia purpurea or Wild 
indigo; Sarphuka/ Kolinji/ 
Paavali/ Mullukai 
Patent claims rejected on 
29 August 2018 
Source: TKDL outcomes against bio-piracy, Traditional Knowledge Digital Library 
 




particular traditional knowledge has enabled the  
Kani tribals to survive for generations altogether in 
travelling large distances in search of food and other 
forest resources. After constant persuasion the Kani 
guides finally led the expedition team and identified 
the plants that are locally known as Arogyapacha and 
scientifically as Trichopus zeylanicusTravancoricus. 
Though Trichopus zeylanicus is also found in Sri 
Lanka and Thailand, only the Indian sub-specie is 
found to possess medicinal properties.
34,35
 
Dr. Palpu Pushpangadan and his team of scientists 
took the Arogyapacha plant to JNTBGRI so as to 
study it scientifically and to look into the possibility 
of commercializing. After undergoing over an eight 
year research constituting several chemical and 
pharmacological tests it was discovered that the fruit 
and the leaves of the plant exhibited properties of 
anti-stress, immune-stimulating, stamina boosting, 
fatigue relieving, controlling tumor growth, activating 
body‘s natural defenses and cellular immune system. 
This followed the isolation of twelve active chemical 
compounds from the Arogyapacha plant that was 
responsible for the effects that the team had 
experienced during their expedition. While the Kani 
tribals traditionally practiced eating the berry fruits of 
the Arogyapacha plant to directly obtain these 
compounds and the benefits associated with them, the 
JNTBGRI team discovered that crushing of the 
Arogyapacha plant leaves was the most effective way 
to obtain the twelve compounds. The JNTBGRI team, 
through a standard research and development program 
successfully conducted clinical trials and scientifically 
demonstrated the critical medicinal benefits of the 
Arogyapacha plant. The JNTBGRI team had in 1994 
decided to file process patent application with the IP 
office in India for the manufacturing of polyherbal 
sports medicine named ‗Jeevani‘ based on the isolated 
chemical compounds from the Arogyapacha plant for 
protection and effective commercialisation of the 
accessed traditional medicinal knowledge for which 
the benefit incurred was intended to be shared with 
the Kani community.
36
 Notably ‗Jeevani‘ was a 
standardized medicinal formulation obtained as an 
end product of the research and development using 
the Arogyapacha plant, its isolated chemical 
compounds and other herbal plants. The intellectual 
property protection for ‗Jeevani‘ was crucial for 
preventing third party misuse and misappropriation 
and for the sharing of benefits by JNTBGRI with the 
indigenous and local communities as per the benefit-
sharing agreement signed with the Kani people, which 
is in accordance with the Access and Benefit Sharing 
(ABS) mechanism of the United Nations Convention 
on Biological Diversity (CBD).
35
 
The product technology licensing for the effective 
commercialisation of ‗Jeevani‘ was granted to Arya 
Vaidya Pharmacy Ltd of Coimbatore for primary 
commercial manufacturing of ‗Jeevani‘ in 1995. The 
initial licensing agreement between JNTBGRI and 
Arya Vaidya Pharmacy Ltdwas for a period of seven 
years and a license fee of $ 50,000 USD. However 
large scale commercial cultivation of Arogyapacha 
plant at the land inhibited by the Kani people, which 
belonged to the Indian Forest Department, caused 
environmental concerns pertaining to land and forest 
degradation, and therefore necessitated prior approval 
and significant challenges. It is here that JNTBGRI 
pointed out the usage of only the leaf part of the 
Arogyapacha plant need to be harvested without 
actually destroying the plant as a whole. It was only 
after JNTBGRI gave assurances to the Forest 
Department and ‗Integrated Tribal Development 
Program‘ of the Directorate for Tribal Welfare, Govt. 
of Kerala, that it would pay Kani people for the seeds 
as well as the leaf-harvests which in turn would fetch 
a stable source of income for the Kani cultivators, that 
the cultivation of Arogyapacha plant was permitted 
by the Forest Department. This followed the training 
and skilling of selected Kani cultivators in cultivation 
and harvesting that enabled JNTBGRI to supply 
Arogyapacha plant leaves to the Arya Vaidya 
Pharmacy Ltd. The formation of Kerala Kani 
Samudaya Kshema Trust in 1997 with people of the 
Kani tribe as its members has the objective to promote 
welfare and development activities amongst the 
members of the Kani community. In March 1999, the 
first royalty payment of US $ 12,500 was received in 
accordance with the benefit sharing agreement that 
have been simultaneously used for various welfare 
projects of the Kani people. Further in 2006, 
JNTBGRI formed a Business Management 
Committee with the Kani people in setting minimum 
conditions for Access and Benefit Sharing (ABS) 
such as extending license and royalty benefits.
35
 
The role played by traditional medicinal knowledge 
in customarily protecting and preserving the 
medicinal secrets of Arogyapacha plant within the 
indigenous Kani tribe is notable. The access to the 
traditional medicinal properties of Arogyapacha 
plant by JNTBGRI, the subsequent commercial 




development and licensing of ‗Jeevani‘ sports drug, 
the ultimate benefit sharing and financial impact on 
the lives of Kani people is but a unique global model 
that signifies the pivotal importance and the need for 
the recognition of traditional medicinal knowledge 
holders and their intellectual property towards 
‗cooperative‘ R&D induced drug discovery in the 
modern times. Kani model is also a epitome of an idea 
of semi-commons that calls for the rights of 
indigenous and local communities. 
 
Protection of Traditional Medicinal Knowledge 
The WIPO postulates the preservation of the 
indigenous community as the best possible way for 
the protection of Traditional Medicinal Knowledge as 
they are linked to the subsistence of the community 
just as seen in the case of the Kani tribe. By 
protecting the indigenous and local communities in 
accordance with their customary laws, practices and 
protocols enables them to pass on from one 
generation to another as a part of their traditional 
obligatory duties. Customary laws and protocols are 
the traditional rules abided by the indigenous 
communities so as to enable the elderly members to 
govern their community. This has been seen as 
important because the customary laws define as to 
how the resources and knowledge of the community 
are shared, utilized and inherited within the 
community so as to prevent inappropriate and 
unauthorized use by those outside the community.  
Apart from the customary laws, there are several 
international instruments that provide Intellectual 
Property Protection of Traditional Medicinal 
Knowledge. The Convention on Biological Diversity, 
1992 recognizes the value of TK of the indigenous 
and local communities. The CBD in Article 8 (j) 
requires the party countries to ―respect, preserve and 
maintain knowledge, innovations and practices of 
indigenous and local communities embodying 
traditional lifestyles relevant for the conservation and 
sustainable use of biological diversity; promote their 
wider application with the approval and involvement 
of the holders of such knowledge, innovations and 
practices; and encourage equitable sharing of benefits 
arising from the utilization of such knowledge, 
innovations and practices. 
The Nagoya Protocol on Access to Genetic 
Resources and the Fair and Equitable Sharing of 
Benefits Arising from their Utilization, 2010, 
objectivizes ―the fair and equitable sharing of the 
benefits arising from the utilization of genetic 
resources, including by appropriate access to genetic 
resources and by appropriate transfer of relevant 
technologies, taking into account all rights over those 
resources and technologies, and by appropriate 
funding, thereby contributing to the conservation of 
biological diversity and the sustainable use of its 
components.‖ 
In India, The Biological Diversity Act, 2002, 
mandates an individual or a body to obtain approval 
from the National Biodiversity Authority to access 
biological resources or Traditional Knowledge 
associated with it for the purposes of research, bio-
survey, bio-utilization or commercial utilization, to 
make any application for obtaining any IPR and 
transfer of any results of research pertaining to 
genetic resources. However, the act has proven to be 
too stringent in enabling the securing of patents so as 
to enable the sharing of knowledge and benefit to the 
traditional knowledge holders. 
 
Conclusion 
The role played by indigenous and local 
communities in the preservation, protection and 
proliferation of traditional knowledge including 
traditional medicinal systems through the respective 
customary and cooperative mechanism as an effective 
tool for wellness management is well evident. 
However the growing concern of biopiracy, 
bioprospecting and misappropriation of Traditional 
Medicinal Knowledge on one side and inappropriate 
claims over the genetic resources through the various 
instruments of intellectual property rights by third 
parties without prior approval has already posed as a 
challenge to the subsistence and survival of the 
indigenous and local communities.
37
 The advent of 
biotechnology and related disciplines such as, 
Ethnopharmacology and Pharmacogenomics has 
scientifically validated traditional medicinals concepts 
such as the humoural theories into factual entities 
thereby attracting greater interest of the modern 
medicine and pharmaceuticals to look into the 
expertise of wellness management and health related 
solution held by traditional medicinal systems. 
Particularly the validation of Tri-dosha as the 
foundational entity of Ayurveda has been attractive 
enough for pharmaceutical companies to 
commercialise herbal medicines and drugs that are 
derived from plant/animal sources. However, the 
traditional medicinal systems are also deep rooted as 
cultural entities that hold multitudinal character and 
immense value among the practitioners of such 






This has importantly been a definite 
outcome of inter-generational interaction of the 
indigenous communities over a greater period of time 
resulting in the carving of substantial necessities and 
economic needs on traditional lines.  
The evolving of an alternative global economic 
regime post the second-world war and the 
disintegration of the USSR on the lines of 
liberalization, privatisation and globalization with 
emphasis on intellectual property rights has increased 
the scope for knowledge as a private entity through 
commercialisation which is in contradictory with the 
perception of knowledge as a common entity for  
the benefit of the social constituents.
39 
This is 
irrespective of the fact that Traditional Medicinal 
Knowledge has historically been a cooperative 
phenomenon at the global stage. The ‗Kani Model‘ of 
access and benefit sharing provides a greater scope 
for furthering the true nature of indigenous and local 
communities with regards to the protection of 
traditional medicinal knowledge on the lines of 
cooperative knowledge sharing and equitable  
benefit mechanism that can be made possible through 
a sui generis instrument.
40 
With this the scope of 
intellectual property as a semi-commons finds greater 
emphasis wherein every stakeholder is benefitted 
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